Preliminary safety evaluation of a taurocholate-conjugated low-molecular-weight heparin derivative (LHT7): a potent angiogenesis inhibitor-Reference-Cited by-同舟云学术

Preliminary safety evaluation of a taurocholate-conjugated low-molecular-weight heparin derivative (LHT7): a potent angiogenesis inhibitor

Published:2014-02-16 Issue:1 Volume:35 Page:104-115
ISSN:0260-437X
Container-title:Journal of Applied Toxicology
language:en
Short-container-title:J. Appl. Toxicol.

Author:

Alam Farzana¹,Chung Seung Woo²,Hwang Seung Rim³,Kim Ji-young²,Park Jooho²,Moon Hyun Tae²⁴,Byun Youngro¹²

Affiliation:

1. Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology; College of Pharmacy, Seoul National University; Seoul 151-742 South Korea

2. Research Institute of Pharmaceutical Sciences, College of Pharmacy; Seoul National University; Seoul 151-742 South Korea

3. College of Pharmacy; Chosun University; 309 Pilmun-daero, Dong-gu Gwangju 501-759 South Korea

4. Mediplex Corp.; Seoul 135-729 South Korea

Funder

the Bio & Medical Technology Department Program

the Converging Research Center Program

World Class University (WCU) program

Publisher

Wiley

Subject

Toxicology

Reference15 articles.

1. Cellular changes in normal blood capillaries undergoing regression after inhibition of VEGF signaling;Baffert;Am. J. Physiol.-Heart C.,2006a

2. Angiopoietin-1 decreases plasma leakage by reducing number and size of endothelial gaps in venules;Baffert;Am. J. Physiol.-Heart C.,2006b

3. Tumor Angiogenesis - Therapeutic Implications;Folkman;N. Engl. J. Med.,1971a

4. Isolation of a Tumor Factor Responsible for Angiogenesis;Folkman;J. Exp. Med.,1971b

5. Mice expressing a humanized form of VEGF-A may provide insights into the safety and efficacy of anti-VEGF antibodies;Gerber;Proc. Natl. Acad. Sci. U. S. A.,2007

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Progress on Heparin–Protamine Particles for Biomedical Application;Polymers;2022-02-25

2. Anticancer Effect of Heparin–Taurocholate Conjugate on Orthotopically Induced Exocrine and Endocrine Pancreatic Cancer;Cancers;2021-11-18

3. Anti‐tumoral effects of low molecular weight heparins: A focus on the treatment of esophageal cancer;Journal of Cellular Physiology;2018-05-09

4. Multi-stage inhibition in breast cancer metastasis by orally active triple conjugate, LHTD4 (low molecular weight heparin-taurocholate-tetrameric deoxycholate);Biomaterials;2016-04

5. Low molecular weight heparin and cancer survival: clinical trials and experimental mechanisms;Journal of Cancer Research and Clinical Oncology;2016-02-24